nadp has been researched along with Allodynia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuzzocrea, S; Doyle, T; Esposito, E; Jacobson, KA; Janes, K; Salvemini, D; Tosh, DK | 1 |
| Bianchi, R; Corsetti, G; Rezzani, R; Rodella, L | 1 |
2 other study(ies) available for nadp and Allodynia
| Article | Year |
|---|---|
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Antineoplastic Agents, Phytogenic; Cytokines; Disease Models, Animal; Excitatory Amino Acid Transporter 2; Hyperalgesia; Male; NADP; Neuralgia; Neuroglia; NF-kappa B; Oxidation-Reduction; Paclitaxel; Rats; Rats, Sprague-Dawley; Signal Transduction; Spinal Cord; Tumor Necrosis Factor-alpha | 2014 |
Nitric oxide involvement in the trigeminal hyperalgesia in diabetic rats.
Topics: Animals; Cell Count; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperalgesia; Hypoglycemic Agents; Insulin; Male; NADP; Neurons; Nitric Oxide; Nitric Oxide Synthase; Nociceptors; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Time Factors; Trigeminal Ganglion; Trigeminal Nerve; Trigeminal Nerve Diseases | 2000 |